KATIE SOMMERICH: Open Payments
NPI 1093441545 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,196 in 22 payments from 4 companies in 2025. Trend: 2023 $658 · 2024 $1,156 · 2025 $1,196
Food & beverage: $1,196
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $378 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $359 |
| ABBVIE INC. | 11 | $311 |
| Teva Pharmaceuticals USA, Inc. | 3 | $148 |
Products named: COBENFY, CAPLYTA, VRAYLAR, UZEDY.
Industry payments across MO — which companies pay providers there.
